Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People with a first diagnosis of early-stage breast cancer where all known cancer has been removed through surgery
- People whose cancer tests positive for estrogen receptors (ER+) and negative for a protein called HER-2 (HER-2-)
- People for whom a clear decision about whether chemotherapy is needed has not yet been made based on current medical guidelines
- People who have agreed to have a gene expression profile (GEP) test, which looks at the activity of certain genes in the tumour
- People who are able to give full informed consent to take part in the IMPARTER study
- People with a good understanding of the Italian language
- People who have access to an internet connection and at least one device, such as a smartphone, tablet, laptop, or desktop computer
Who may not be able to join:
- People who have another type of breast cancer diagnosis, such as ductal carcinoma in situ or metastatic (spread) breast cancer
- People who are not able to give fully informed consent to participate
- People who are under 18 years of age
- People who are unable to understand and speak Italian
- People who do not have access to an internet connection or a suitable device
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gabriella Pravettoni, MD, European Istitute of Oncology
Phone: +39 0257489731
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
GEP Knowledge Evaluation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.